Health Products

Immulite System- IGF-1 (Insulin like Growth Hormone) - 1000 and 2000 Assay (2017-11-30)

· Published by Health Canada · Official notice

Details

Alert type: Medical Device Recall
Category: Medical Device
Issue: Medical Devices
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameModel or catalog number
Not applicable
Manufacturer
Siemens Healthcare Diagnostics Products Limited
Glyn Rhonwy
Llanberis
LL55 4EL
UNITED KINGDOM
B. Immulite System - IGF-1 (Insulin like Growth Hormone) AssayLKIGF1
Not applicable
Manufacturer
Siemens Healthcare Diagnostics Products Limited
Glyn Rhonwy
Llanberis
LL55 4EL
UNITED KINGDOM
C. Immulite 1000 System - IGF-1 AssayLKIGF1
Not applicable
Manufacturer
Siemens Healthcare Diagnostics Products Limited
Glyn Rhonwy
Llanberis
LL55 4EL
UNITED KINGDOM
A. Immulite 2000 System - IGF-1 (Insulin like Growth Hormone) AssayL2KIGF2

Introduction

Affected Products

A. Immulite 2000 System- IGF-1 (Insulin Like Growth Hormone) Assay
B. Immulite System- IGF-1 (Insulin Like Growth Hormone) Assay
C. Immulite 1000 System- IGF-1 Assay

Reason

In response to customer feedback, Siemens evaluated alternate statistical methods to determine if an alternate method would be a better fit for the reference range data published in the Information for Use (IFU). Our investigation concluded that the LMS method provided a better fit to the data and produced ranges more consistent with the expected physiological change in IGF-I levels compared to use of the weighted average results reported in the IFU.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime